Rutu Rathod | Public Health | Best Researcher Award

Posted on 31/12/202431/12/2024 by ScienceFather

Dr. Rutu Rathod | Public Health | Best Researcher Award

Dr. Rutu Rathod, University of Arkansas for Medical Sciences, United States

🎓 Dr. Rutu A. Rathod, PhD, MPH, MBBS is an Assistant Professor of Epidemiology at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She earned her PhD in Epidemiology from the University of Memphis, MPH from Texas A&M University, and MBBS from Sumandeep Vidyapeeth University, India. Dr. Rathod specializes in cancer epidemiology, DNA methylation, and health disparities. With numerous publications, honors, and funded research projects, she is advancing the understanding of social determinants of health and their impact on chronic diseases. 📊🌎

Publication Profile

Google Scholar

Academic Journey 🎓

Dr. Rutu Rathod is a dedicated public health professional with a strong academic foundation. She earned her Ph.D. in Epidemiology in 2021 from the University of Memphis, specializing in Biostatistics and Environmental Health Sciences. Prior to this, she completed her Master of Public Health (MPH) in Epidemiology in 2018 at Texas A&M University, gaining expertise in epidemiological research and biostatistical methods. Dr. Rathod began her academic journey with a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2015 from Sumandeep Vidyapeeth University, India, laying the groundwork for her career in healthcare and research. 🌍📊🔬

Professional Experiences

Dr. Rutu Rathod is an accomplished epidemiologist with diverse professional experiences. Currently, she serves as an Assistant Professor (Tenure-track) at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and as a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She is also an Adjunct Assistant Professor at the University of Texas Southwestern Medical Center. Her prior roles include Graduate Research Assistantships, focusing on DNA methylation, asthma, obesity, and prenatal alcohol exposure, as well as clinical roles as a physician and intern in India. 🧬🩺📚

Honors and Awards

Dr. Rutu Rathod has received numerous accolades for her contributions to public health and academic research. She earned the prestigious Gold Medallion as a Public Health Scholar at Texas A&M University in 2018. At the University of Memphis, she was recognized with the Student Accomplishment Award (2021) and multiple travel awards (2019-2020). Dr. Rathod also secured second place at the 32nd Annual Student Research Forum (2020) in Life and Health Sciences and received the School of Public Health Student Achievement Award. Her dedication to research and excellence is further highlighted by awards from the Department of Neuroscience. 🎓🏆📊

Research Focus

Dr. Rutu Rathod’s research centers on the intersection of epigenetics and respiratory health. Her work explores how DNA methylation mediates the impact of early-life BMI trajectories on asthma and lung function in adulthood. She investigates sex-specific associations between asthma and epigenetic changes, the role of methylation in coronavirus-related gene expression, and chronic disease risk factors like myocardial infarction. Dr. Rathod contributes significantly to understanding gene-environment interactions and their effects on respiratory conditions, with a focus on using epigenetic markers for disease prediction and prevention. Her research bridges epidemiology and molecular biology. 📊🩺📖

Publication Top Notes

Sex‐specific associations of asthma acquisition with changes in DNA methylation during adolescence (29 citations, 2021) 📄🧬
BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (18 citations, 2021) 📊🌬️
Methylation of host genes associated with coronavirus infection from birth to 26 years (9 citations, 2021) 🦠🧬
Association of childhood BMI trajectory with post-adolescent and adult lung function mediated by pre-adolescent DNA methylation (7 citations, 2022) 📈🌬️
Association of asthma and rhinitis with epigenetics of coronavirus-related genes (5 citations, 2021) 🤧🧬
BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (1 citation, 2021) 📊🩺
Epidemiological Studies on Risk Factors of Chronic Diseases (No citations, 2021) 📘📊
Risk factors of myocardial infarction at later age in healthy middle-aged men (No citations, 2020) 🫀📊
The Association of Asthma Acquisition with DNA Methylation Changes During Adolescence Is Gender-Specific (No citations, 2020) 🧬👩‍⚕️
Association of BMI Trajectory in Earlier Childhood with Lung Function in Adulthood Mediated by DNA Methylation (No citations, 2020) 📈🌬️
BMI Trajectory in Childhood Associated with Asthma at Young Adulthood Mediated by DNA Methylation (No citations, 2019) 🧬📊

Arezou Mehrabi | biomedical science | Best Researcher Award

Posted on 28/10/202428/10/2024 by ScienceFather

Assist. Prof. Dr Arezou Mehrabi | biomedical science | Best Researcher Award

Assist. Prof. Dr, Islamic Azad University – Tonekabon Branch, Iran

Arezou Mehrabi, born in Mazandaran, Iran, is a tissue engineering researcher known for her innovative work in biomedical materials. She completed her Ph.D. in Tissue Engineering at Iran University of Medical Sciences, focusing on bioactive hydrogels for wound healing. With a strong foundation in anatomical science (M.Sc.) from Tarbiat Modares University and a B.Sc. in Radiology from Mashhad University of Medical Sciences, Mehrabi’s research is primarily devoted to advancing regenerative medicine, particularly for cardiac and bone tissue applications. Her work includes various publications and collaborations, shaping her as a prominent figure in tissue engineering.

Publication Profile

scholar

Education 🎓

Mehrabi obtained her Ph.D. in Tissue Engineering from Iran University of Medical Sciences (2018-2023), presenting a thesis on in-situ forming hydrogels for wound healing. Previously, she earned an M.Sc. in Anatomical Science (2015-2017) from Tarbiat Modares University, focusing on electroactive carbon nanofiber cardiac patches. Her academic journey began with a B.Sc. in Radiology at Mashhad University of Medical Sciences (2011-2015). These academic credentials provided a strong multidisciplinary background, supporting her expertise in biomedical and tissue engineering.

Experience 💼

Mehrabi’s professional experience includes significant contributions to tissue engineering, with a specialization in electroactive and bioactive hydrogels. Her research has focused on applications in cardiac and bone regeneration, including projects on nanofiber cardiac patches and electroconductive scaffolds. She has collaborated on diverse projects and has presented her findings at numerous international conferences. Her work has also led to the development of patents in electroactive cardiac patches and innovative biomaterials for regenerative medicine.

Awards and Honors 🏆

Mehrabi has earned recognition for her contributions, including a certified patent for an electroactive cardiac patch awarded by the Iranian Research Organization for Science and Technology (IROST, Patent No. 94280). She has also co-authored influential studies and book chapters and contributed to significant scientific publications. Her dedication to research has positioned her as a key innovator in tissue engineering, especially in developing new materials for cardiac and bone tissue engineering.

Research Focus 🔬

Mehrabi’s research is centered on biomaterials for tissue engineering, with a focus on bioactive and electroactive materials for cardiac and wound healing applications. Her notable projects include developing carbon nanofiber-based cardiac patches and hydrogels that promote vascularization and regeneration. Mehrabi is also exploring advanced applications for natural polymers in cancer diagnosis and treatment. Her work in regenerative medicine aims to advance sustainable, innovative solutions for therapeutic applications in healthcare.

Publication Top Notes

Electroactive Cardiac Patch
Development of a novel electroactive cardiac patch based on carbon nanofibers and gelatin encouraging vascularization
A. Mehrabi, N. Baheiraei, M. Adabi, Z. Amirkhani
Applied Biochemistry and Biotechnology 190, 931-948, 47 citations (2020)

In-Situ Hydrogel for Wound Healing
In-situ forming hydrogel based on thiolated chitosan/carboxymethyl cellulose (CMC) containing borate bioactive glass for wound healing
A. Mehrabi, A. Karimi, S. Mashayekhan, A. Samadikuchaksaraei, PB Milan
International Journal of Biological Macromolecules 222, 620-635, 26 citations (2022)

Hydrogel for Breast Reconstruction
Synthesis and characterization of a silk fibroin/placenta matrix hydrogel for breast reconstruction
A. Mehrabi, S. Mousazadeh, A. Mollafilabi, N. Nafissi, PB Milan
Life Sciences 334, 122236, 7 citations (2023)

Bone Tissue Engineering
Evaluation of inherent properties of the carboxymethyl cellulose (CMC) for potential application in tissue engineering focusing on bone regeneration
A. Mehrabi, SZ Jalise, A. Hivechi, S. Habibi, MM Kebria, MA Haramshahi
Polymers for Advanced Technologies 35 (1), e6258, 5 citations (2024)

Vasculogenesis and Angiogenesis
Molecular mediators of vasculogenesis and angiogenesis
M. Amoupour, MM Kebria, A. Hivechi, N. Peyravian, M. Ghasemian
Biomaterials for Vasculogenesis and Angiogenesis, 13-37, 5 citations (2022)

Cell Sources in Cardiac Tissue Engineering
Cell sources in cardiac tissue engineering: current choices
PB Milan, N. Amini, A. Mehrabi, S. Mousazadeh, S. Ababzadeh, A. Rezapour
Current Stem Cell Research & Therapy 16 (6), 745-752, 5 citations (2021)

Electroconductive Scaffolds
Electroconductive Scaffolds: A New Strategy in Cardiac Tissue Engineering
A. Mehrabi, N. Baheiraei
Pathobiology Research 21 (2), 107-111, 2 citations (2018)

Natural Polymers in Cancer Treatment
Natural polymers for diagnosis and treatment of cancers
A. Mehrabi, R. Najafloo, H. Valizadeh, VH Sarmadi, S. Naderi
Biomaterials for Precision Cancer Medicine, 123-153, 2025

In Situ Fibrin Scaffold for Bone Engineering
Development of in situ forming autologous fibrin scaffold incorporating synthetic teriparatide peptide for bone tissue engineering
MR Khalili, A. Molafilabi, S. Mousazadeh, A. Mehrabi, J. Kiani
The International Journal of Artificial Organs, 2024

Morphine’s Effects on the CNS
The effects of morphine administration on the central nervous system (CNS): advantages and disadvantages
A. Mehrabi, BL Aghaee, S. Farrokhfar
Neuroscience Research Notes 7 (2), 2024

Conclusion

Dr. Arezou Mehrabi is an exceptional candidate for the Best Researcher Award, with extensive expertise in tissue engineering and biomedical science. Her dedication to pioneering research in tissue engineering, particularly in wound healing and cardiac applications, as well as her solid publication and patent record, highlight her as a leading scientist in her field. While there are areas where expanding international collaboration and public outreach could further amplify her impact, Dr. Mehrabi’s innovative approach, academic accomplishments, and contributions to practical medical solutions make her highly deserving of recognition as a top researcher.

Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Posted on 07/10/202407/10/2024 by ScienceFather

Dr. Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Dr. Rasheedat Balogun, University College Hospital Ibadan/ Fertpromax Consult, Nigeria

Dr. Rasheedat Omolola Balogun 🎓 is a distinguished Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult, Lagos, Nigeria. With an MB; BS from the University of Ibadan (2013), she excelled as the Best Graduating Student in Surgery. Dr. Balogun has received multiple accolades, including Overall Best Candidate and Best Female Candidate in Obstetrics & Gynaecology from the West African College of Surgeons (2020). Her research contributions include publications in prominent journals, focusing on pregnancy-related cases.

Publication profile

Orcid

Educational Background

Dr. Rasheedat Omolola Balogun holds a distinguished educational background in medicine and surgery. She earned her MB; BS degree from the University of Ibadan, College of Medicine, in 2013, where she graduated as the Best Graduating Student in Surgery. In 2020, she became a member of the West African College of Surgeons (MWACS) in Obstetrics and Gynaecology. Recently, in 2023, Dr. Balogun attained the Fellow of the Medical College of Obstetrics and Gynaecology (FMCOG) designation from the National Postgraduate Medical College of Nigeria. Her foundational education was completed at the Federal Government College, Ijanikin, Lagos, where she earned her WASSC in 2005. 📚✨

Professional Experience

Dr. Rasheedat Omolola Balogun is a highly skilled Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult in Gbagada, Lagos, since February 2024. Previously, she served as Chief Resident in Obstetrics and Gynaecology at University College Hospital (UCH), Ibadan, from November 2022 to October 2023. Dr. Balogun also held the position of Senior Resident in the Assisted Conception Unit (IVF) at UCH from December 2020 to October 2023 and completed her residency in Obstetrics and Gynaecology from 2017 to 2020. Her medical journey began as a House Officer at UCH (2013-2014), with roles as a Medical Officer at several hospitals, including Get-Well Hospital and TZ Hospital. 🌟🏥

Dr. Rasheedat Omolola Balogun has received several prestigious awards in recognition of her outstanding contributions and achievements. In 2023, she was honored by University College Hospital (UCH), Ibadan, for her dedication and growth contributions to the hospital. She also earned the UCH Shalina Rising Star award, being recognized as one of the top six best residents’ dissertations and finishing as the first runner-up. Additionally, Dr. Balogun received the Professor Vincent Aimakhu Prize from the West African College of Surgeons in 2021 for being the best candidate in the 2020 membership examinations, along with the Eusebe Alihonou Prize for being the best female candidate. 🌟✨

Conclusion

Dr. Rasheedat Balogun embodies the qualities sought in a recipient of the Research for Best Researcher Award. Her exceptional educational achievements, extensive clinical experience, impactful research contributions, and recognition by peers demonstrate her unwavering commitment to the field of obstetrics and gynecology. She stands out as a candidate who not only contributes to medical science but also inspires future generations of healthcare professionals.

Publication Top Notes

A randomized controlled trial on the comparison of two doses of carbetocin with oxytocin for the prevention of postpartum hemorrhage (Concert Trial), Journal of Obstetrics and Gynaecology Research (2024) DOI: 10.1111/jog.16097 🩺
Assessment of anxiety and depression, and coping mechanisms during COVID-19 lockdown among pregnant women, Heliyon (2022) DOI: 10.1016/j.heliyon.2022.e10902 😷
Outcomes following cervical cerclage at the University College Hospital. A retrospective analysis, Conference paper (Year not specified) 📄

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Posted on 18/09/202418/09/2024 by ScienceFather

Prof Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor, Exeltis, Germany

Born on January 5, 1964, in Madrid, Spain, Prof. Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Prof. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Prof. Dr. Pedro Antonio Regidor, born on January 5, 1964, in Madrid, Spain, and holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Prof. Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

“The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
“OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
“Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
“Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
“10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
“Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
“Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
“The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
“Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
“Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅

Conclusion

Prof. Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on 23/08/202423/08/2024 by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

Research focus

The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

James Yue | Health Professions Award | Best Researcher Award

Posted on 16/08/202416/08/2024 by ScienceFather

Dr. James Yue | Health Professions Award | Best Researcher Award

Dr. James Yue, Frank H Netter School of Medicine/ CT Orthopaedics, United States

Dr. James J. Yue’s impressive career makes him a strong candidate for the Research for Best Researcher Award.

Publication profile

Scopus

Extensive Expertise

Dr. Yue is a renowned spinal surgeon with a significant academic and clinical background, including leadership roles and contributions to major institutions like Quinnipiac University and Yale University.

Innovative Contributions

He has pioneered numerous advancements in spinal surgery, notably through founding specialized centers such as the Northeast Alliance Surgery Center and the New England Center for Disc Replacement.

Recognized Achievements

His awards, including multiple “Best Doctor” titles and the Gunnar B. Andersson Distinguished Service Award, highlight his contributions and recognition in his field.

Research Impact

Dr. Yue’s extensive bibliography, with numerous peer-reviewed articles, showcases his research impact and ongoing commitment to advancing spinal surgery techniques and treatments.

Publication Top Notes

“Surgical treatment of refractory low back pain using implanted BurstDR spinal cord stimulation (SCS) in a cohort of patients without options for corrective surgery: Findings and results from the DISTINCT study, a prospective randomized multi-center-controlled trial” – Yue, J.J., Gilligan, C.J., Falowski, S., Okaro, U., Deer, T. (2024) North American Spine Society Journal – 🩺
“Endovascular stenting of external iliac vein injury during anterior spine exposure” – Arun, A.S., Yue, J.J., Khachane, V.B., Sumpio, B., Tonnessen, B.H. (2024) Journal of Vascular Surgery Cases, Innovations and Techniques – 🩺
“Paired Comparison Survey Analysis Utilizing Rasch Methodology of the Relative Difficulty and Estimated Work Relative Value Units of CPT Code 0202T” – Lorio, M., Lewandrowski, K.-U., Yeager, M.T., Kube, R., Yue, J. (2024) International Journal of Spine Surgery – 📊
“A novel antibacterial compound decreases MRSA biofilm formation without the use of antibiotics in a murine model” – Bouloussa, H., Durand, Z., Gibon, E., Bouloussa, O., Croisier, D. (2024) Journal of Orthopaedic Research – 🦠
“Implant Surface Technologies to Prevent Surgical Site Infections in Spine Surgery” – Bouloussa, H., Mirza, M., Ansley, B., Jilakara, B., Yue, J.J. (2023) International Journal of Spine Surgery – 🦠
“Treatment of Refractory Low Back Pain Using Passive Recharge Burst in Patients Without Options for Corrective Surgery: Findings and Results From the DISTINCT Study, a Prospective Randomized Multicenter Controlled Trial” – Deer, T., Gilligan, C., Falowski, S., Fahey, M.E., Yue, J. (2023) Neuromodulation – 🩺
“Burst spinal cord stimulation can attenuate pain and its affective components in chronic pain patients with high psychological distress: results from the prospective, international TRIUMPH study” – Hagedorn, J.M., Falowski, S.M., Blomme, B., Capobianco, R.A., Yue, J.J. (2022) Spine Journal – 💥
“Final long-term reporting from a randomized controlled IDE trial for lumbar artificial discs in single-level degenerative disc disease: 7-year results” – Radcliff, K., Zigler, J., Braxton, E., Situ, A., Yue, J. (2021) International Journal of Spine Surgery – ⏳
“Postoperative Bracing on Pain, Disability, Complications, and Fusion Rate following 1-3+ Level Lumbar Fusion in Degenerative Conditions: A Meta-Analysis” – Jones, J.J., Oduwole, S., Feinn, R., Yue, J.J. (2021) Clinical Spine Surgery – 📉
“International society for the advancement of spine surgery policy 2019-surgical treatment of lumbar disc herniation with radiculopathy” – LORIO, M., KIM, C., ARAGHI, A., INZANA, J., YUE, J.J. (2020) International Journal of Spine Surgery – 📜

Conclusion

Given these factors, Dr. Yue’s profile aligns well with the criteria for the Research for Best Researcher Award, making him a suitable candidate.

Enguo Cao | Health Professions | Best Researcher Award

Posted on 24/07/202424/07/2024 by ScienceFather

Enguo Cao | Health Professions | Best Researcher Award

Prof Dr Enguo Cao, Jiangnan University, China

Prof. Cao Enguo 🧑‍🏫 is a distinguished professor and doctoral supervisor at Jiangnan University, China. With a Ph.D. from Japan, he leads the Intelligent Interaction Design Laboratory and serves as deputy director of the Key Laboratory of China Light Industry. His research focuses on intelligent product design and human biomimetic interaction, resulting in over 30 papers and 20+ patents. He has led numerous research projects, including grants from the National Natural Science Foundation of China. Prof. Cao has earned several accolades, including the Yoneyama Rotary Memorial Award and the title of “Top Six Talent Peaks” in Jiangsu Province. 🌟🔬📚

Publication profile

Scopus

Research Interests

Intelligent Interaction System Design focuses on creating advanced systems that enhance user experiences through smart and responsive technology. This field encompasses the development of interactive interfaces that adapt to user needs, leveraging artificial intelligence and machine learning to offer intuitive and personalized interactions. The goal is to build systems that not only respond to user inputs but also predict and adapt to their preferences, providing a seamless and engaging experience. Such designs are pivotal in various applications, from smart home devices to sophisticated customer service bots, aiming to make technology more accessible and user-friendly.

Research focus

Dr. Enguo Cao’s research primarily focuses on wearable health devices, exoskeleton design, and user experience in robotics. His work includes designing and evaluating various types of exoskeletons for rehabilitation and mobility enhancement, such as passive lower limb exoskeletons and multi-resiliency models. He also explores the integration of emotional and social factors into user experience, aiming to improve interaction with automated systems and devices. His contributions include studies on the physiological effects of exoskeletons during physical activities and data-driven frameworks for predicting user expectations. His research is crucial for advancing assistive technologies and enhancing their practical application. 🤖🦵📊